Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome;Nicotinamida adenina dinucleótido (NADH) en pacientes con síndrome de fatiga crónica

Revista Clinica Espanola

Volumn 210, Issue 6, 2010, Pages 284-288

  Alegre, J ^a   Roses J M ^b   Javierre, C ^c   Ruiz Baques A ^d   Segundo, M J ^e   Fernandez De Sevilla T ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Instituto de Biometra Aplicada   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Campus UAB   (Spain)

^e Laboratories VITA SA   (Spain)

Author keywords

Chronic fatigue syndrome; Clinical trial; NADH

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; PLACEBO; UNCLASSIFIED DRUG; VITANADH;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE; EXERCISE TEST; FEMALE; FUNCTIONAL ASSESSMENT; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SLEEP; SUPPLEMENTATION; FATIGUE SYNDROME, CHRONIC; MIDDLE AGED; PROSPECTIVE STUDY;

DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NAD; PROSPECTIVE STUDIES;

EID: 77953554504     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2009.09.015     Document Type: Article

References (15)

1. S. Reid, T. Chalder, A. Cleare, M. Hotopf, and S. Wessely Chronic fatigue syndrome BMJ 320 2000 292 296
2. D. Chambers, A.M. Bagnall, S. Hempel, and C. Forbes Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis. An updated systematic review J Royal Soc Medicine 99 2006 506 520
3. P. Henningsen, S. Zipfel, and W. Herzog Management of functional somatic syndromes Lancet 369 2007 946 955
4. S.E. Shetzline, C. Martinand-Mari, N.L. Reichenbach, Z. Buletic, B. Lebleu, and W. Pfleiderer Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome J Interferon Cytokine Res 22 2002 443 456
5. L.M. Forsyth, H.G. Preuss, A.L. MacDowell, L. Chiazze Jr, G.D. Birkmayer, and J.A. Bellanti Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome Ann Allergy Asthma Immunol 82 1999 185 191
6. A. Mero, R. Raitanen, J. Birkmayer, and P. Komi Effects of nicotinamide adenine dinucleotide hydide on physical and mental performance J Sports Sciences 26 2008 311 319
7. M.L. Santaella, I. Font, and O.M. Disdier Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome P R Health Sci J 23 2004 89 93
8. K. Fukuda, S.E. Straus, I. Hickie, M.C. Sharpe, J.G. Dobbins, A.L. Komaroff and The International Chronic Fatigue Syndrome Study Group The Chronic Fatigue Syndrome: A comprehensive Approach to its Definition and Study Ann Int Med 121 1994 953 959
9. National Center for Infectious Diseases. Centers for Disease Control and Prevention. National Institute of Allergy and Infectious Diseases. National Institute of Health. Disponible en: http://www.cdc.gov/cfs
10. C.C. Schag, R.L. Heinrich, and P.A. Ganz Karnofsky performance status revisited: Reliability, validity, and guidelines J Clin Oncology 2 1984 187 193
11. M.J. Herrero, J. Blanch, J.M. Peri, J. De Pablo, L. Pintor, and A. Bulbena A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population Gen Hosp Psychiatry 25 2003 277 283
12. J.D. Fisk, P.G. Ritvo, L. Ross, D.A. Haase, T.J. Marrie, and W.F. Schlech Measuring the functional impact of fatigue. Initial validation of the Fatigue Impact Scale Clin Infect Dis 18 Suppl. 1 1994 S79 S83
13. J. Alonso, L. Prieto, and J.M. Ant La version espaola del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrument para la medida de los resultados clnicos Med Clin (Barc) 104 1995 771 776
14. J.S. Carpenter, and M.A. Andrykowski Psychometric evaluation of the Pittsburgh Sleep Quality Index J Psychosom Res 45 1998 5 13
15. P. De Becker, J. Roeykens, M. Reynders, N. McGregor, and K. De Meirleir Exercise capacity in chronic fatigue syndrome Arch Intern Med 160 2000 3270 3277